Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Heart Failure

Free Subscription 10.08.2026 1 Am Heart J 1 Basic Res Cardiol 3 Circ Heart Fail 1 Circulation 5 Eur Heart J 1 Eur J Heart Fail 4 J Am Coll Cardiol 2 J Card Fail 1 J Cardiol 1 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. NOGI K, Tanaka A, Imai T, Doi S, et al
   Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor-neprilysin inhibition in acute heart failure: insights from the PREMIER study.
   Am Heart J. 2026 Aug 1:107549. doi: 10.1016/j.ahj.2026.107549.
   PubMed         Abstract available
   
   

   
   Basic Res Cardiol

2. MCNAMARA JW, Song T, Alam P, Baby A, et al
   Fast skeletal myosin binding protein-C expression exacerbates dysfunction in heart failure.
   Basic Res Cardiol. 2026 Aug 5. doi: 10.1007/s00395-026-01202.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

3. BUTT JH, Jhund PS, Henderson AD, Talebi A, et al
   MRAs and Race in Heart Failure: An Individual Participant Data Meta-Analysis of Randomized Trials.
   Circ Heart Fail. 2026 Aug 7:e014355. doi: 10.1161/CIRCHEARTFAILURE.125.014355.
   PubMed         Abstract available
   
   
4. LU L, Abou Kamar S, Palm CL, Scholte NTB, et al
   Serially Measured Metabolic Plasma Biomarkers and Adverse Outcomes in Chronic Heart Failure: A Longitudinal NMR Spectroscopy Study in Two Cohorts.
   Circ Heart Fail. 2026 Aug 6:e013971. doi: 10.1161/CIRCHEARTFAILURE.125.013971.
   PubMed         Abstract available
   
   
5. STONE GW, Lindenfeld J, Zile MR, Anker SD, et al
   Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial.
   Circ Heart Fail. 2026 Aug 4:e014100. doi: 10.1161/CIRCHEARTFAILURE.125.014100.
   PubMed         Abstract available
   
   

   
   Circulation

6. MORA-AYESTARAN N, Ramos-Lopez N, Ochoa JP, Ibargoyen AY, et al
   Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy.
   Circulation. 2026;154:440-453.
   PubMed         Abstract available
   
   

   
   Eur Heart J

7. KOBAYASHI M, Pitt B, Zannad F
   Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction.
   Eur Heart J. 2026 Aug 3:ehag578. doi: 10.1093.
   PubMed         Abstract available
   
   
8. JANKOWSKI J, Wu Z
   Paraspeckles, ferroptosis, and cardiac hypertrophy: a new axis in heart failure biology.
   Eur Heart J. 2026 Aug 5:ehag207. doi: 10.1093.
   PubMed        
   
   
9. BROWN JM, Cunningham JW
   Mineralocorticoid inhibition in heart failure: does one size fit all?
   Eur Heart J. 2026 Aug 6:ehag603. doi: 10.1093.
   PubMed        
   
   
10. LINDE C
    Do women and men have equal benefits from heart failure medications?
    Eur Heart J. 2026 Aug 8:ehag559. doi: 10.1093.
    PubMed        
    
    
11. TOHYAMA T, Ikeda M, Watanabe T, Enzan N, et al
    Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies.
    Eur Heart J. 2026 Aug 8:ehag577. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur J Heart Fail

12. 
    Correction to 'What's New in Heart Failure? May-June 2024' , 'What's New in Heart Failure? June-July 2024', 'What's New in Heart Failure? August-September 2024', 'The Month in Heart Failure! September 2024', 'What's New in Heart Failure? October
    Eur J Heart Fail. 2025;27:1793-1794.
    PubMed        
    
    

    
    J Am Coll Cardiol

13. PETRIE MC, Januzzi JL, Harrington J, Taub P, et al
    Preventing Heart Failure: At-Risk Populations and the Role of Biomarkers.
    J Am Coll Cardiol. 2026;88:571-574.
    PubMed        
    
    
14. GONG J, Chiu N, Clinch KA, Qian Y, et al
    Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome.
    J Am Coll Cardiol. 2026 Jun 17:S0735-1097(26)06350.
    PubMed         Abstract available
    
    
15. KHAN SS, Ndumele CE, Bhave N, Blumenthal RS, et al
    Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Ca
    J Am Coll Cardiol. 2026 Jun 9:S0735-1097(26)06493.
    PubMed         Abstract available
    
    
16. FOA A, Pabon MA, Filippatos G, Claggett BL, et al
    Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis.
    J Am Coll Cardiol. 2026;88:628-641.
    PubMed         Abstract available
    
    

    
    J Card Fail

17. FERREIRA JP, Zannad F, Filippatos G, Marques P, et al
    Impact of empagliflozin on serum calcium and phosphate in heart failure.
    J Card Fail. 2026 Aug 7:S1071-9164(26)00456.
    PubMed         Abstract available
    
    
18. TAMURA T, Nagai T, Nakao M, Tahara S, et al
    Erythropoietin Resistance and Outcomes According to SGLT2 Inhibitor Use in Anemic Patients With Heart Failure.
    J Card Fail. 2026 Aug 7:S1071-9164(26)00451.
    PubMed        
    
    

    
    J Cardiol

19. JURIN I, Vidak M, Covic I, Besic D, et al
    Baseline red cell distribution width-to-albumin ratio and 12-month outcomes in sodium-glucose cotransporter 2 inhibitor-treated heart failure.
    J Cardiol. 2026 Aug 5:S0914-5087(26)00159-0. doi: 10.1016/j.jjcc.2026.
    PubMed         Abstract available
    
    

    
    N Engl J Med

20. HEERSPINK HJL, Neuen BL, Agarwal R, Cherney DZI, et al
    Finerenone in Persons with Chronic Kidney Disease without Diabetes.
    N Engl J Med. 2026 Jun 4. doi: 10.1056/NEJMoa2604625.
    PubMed         Abstract available
    
    

    
    PLoS One

21. CHAVEZ-INIGUEZ JS, Zaragoza JJ, Del Toro RE, Fong-Maravilla I, et al
    Impact of infection on decongestion and kidney outcomes in patients with cardiorenal syndrome type 1.
    PLoS One. 2026;21:e0355608.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum